|
2020-08-31
|
Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
published
| article-journal
| CC-BY
doi:10.3390/cells9091998
|
|
2019-10-17
|
Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
published
| article-journal
| CC-BY
doi:10.3390/cancers11101581
|
|
2020-10-20
|
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
published
| article-journal
| CC-BY
doi:10.3390/cancers12103051
|
|
2021-05-07
|
A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value
published
| article-journal
| CC-BY
doi:10.3390/cancers13092252
|
|
2021-09-16
|
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
published
| article-journal
| CC-BY
doi:10.3390/pharmaceutics13091485
|
|
2022-03-04
|
Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance
published
| article-journal
| CC-BY
doi:10.3390/cancers14051321
|
|
2022-04-04
|
Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas
published
| article-journal
doi:10.1002/pbc.29575
|
|
2023-02-16
|
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
published
| article-journal
| CC-BY
doi:10.3390/cancers15041268
|
|
2021-09-30
|
Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring
published
| article-journal
| CC-BY
doi:10.3390/cancers13194926
|
|
2023-02-28
|
p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
published
| article-journal
doi:10.3390/cancers15051512
|